200 related articles for article (PubMed ID: 24286160)
1. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin attenuates the development of pulmonary and cutaneous fibrosis in a murine model of systemic sclerosis.
Bagnato G; Bitto A; Pizzino G; Irrera N; Sangari D; Cinquegrani M; Roberts WN; Matucci Cerinic M; Squadrito F; Altavilla D; Bagnato G; Saitta A
Rheumatology (Oxford); 2013 Aug; 52(8):1377-86. PubMed ID: 23620550
[TBL] [Abstract][Full Text] [Related]
3. Propylthiouracil modulates aortic vasculopathy in the oxidative stress model of systemic sclerosis.
Bagnato G; Bitto A; Pizzino G; Roberts WN; Squadrito F; Altavilla D; Bagnato G; Saitta A
Vascul Pharmacol; 2015 Aug; 71():79-83. PubMed ID: 25869518
[TBL] [Abstract][Full Text] [Related]
4. Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.
Bagnato GL; Irrera N; Pizzino G; Santoro D; Roberts WN; Bagnato G; Pallio G; Vaccaro M; Squadrito F; Saitta A; Altavilla D; Bitto A
Clin Sci (Lond); 2018 Jan; 132(2):231-242. PubMed ID: 29237724
[TBL] [Abstract][Full Text] [Related]
5. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis.
Bitto A; Bagnato GL; Pizzino G; Roberts WN; Irrera N; Minutoli L; Russo G; Squadrito F; Saitta A; Bagnato GF; Altavilla D
Free Radic Res; 2016; 50(5):514-22. PubMed ID: 26846205
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
[TBL] [Abstract][Full Text] [Related]
9. The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
Marut WK; Kavian N; Servettaz A; Nicco C; Ba LA; Doering M; Chéreau C; Jacob C; Weill B; Batteux F
J Invest Dermatol; 2012 Apr; 132(4):1125-32. PubMed ID: 22277946
[TBL] [Abstract][Full Text] [Related]
10. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
11. Effects of propylthiouracil and bromocryptine on serum concentrations of thyrotrophin and thyroid hormones in normal female horses.
Johnson PJ; Messer NT; Ganjam VK; Thompson DL; Refsal KR; Loch WE; Ellersieck MR
Equine Vet J; 2003 May; 35(3):296-301. PubMed ID: 12755434
[TBL] [Abstract][Full Text] [Related]
12. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
13. Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.
Kavian N; Servettaz A; Mongaret C; Wang A; Nicco C; Chéreau C; Grange P; Vuiblet V; Birembaut P; Diebold MD; Weill B; Dupin N; Batteux F
Arthritis Rheum; 2010 Nov; 62(11):3477-87. PubMed ID: 20583103
[TBL] [Abstract][Full Text] [Related]
14. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
Front Immunol; 2018; 9():2571. PubMed ID: 30455706
[No Abstract] [Full Text] [Related]
15. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
[TBL] [Abstract][Full Text] [Related]
16. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
[TBL] [Abstract][Full Text] [Related]
17. Leflunomide prevents ROS-induced systemic fibrosis in mice.
Morin F; Kavian N; Chouzenoux S; Cerles O; Nicco C; Chéreau C; Batteux F
Free Radic Biol Med; 2017 Jul; 108():192-203. PubMed ID: 28365359
[TBL] [Abstract][Full Text] [Related]
18. Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice.
Theodossiou C; Skrepnik N; Robert EG; Prasad C; Axelrad TW; Schapira DV; Hunt JD
Cancer; 1999 Oct; 86(8):1596-601. PubMed ID: 10526291
[TBL] [Abstract][Full Text] [Related]
19. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis.
Hua-Huy T; Le-Dong NN; Duong-Quy S; Bei Y; Rivière S; Tiev KP; Nicco C; Chéreau C; Batteux F; Dinh-Xuan AT
J Breath Res; 2015 Jun; 9(3):036007. PubMed ID: 26079155
[TBL] [Abstract][Full Text] [Related]
20. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
de Almeida AR; Dantas AT; de Oliveira Gonçalves ME; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; Cunha EGC; de Azevedo Valadares LD; de Melo Gomes JV; de Paula SKS; da Rocha Pitta MG; da Rocha Pitta I; de Melo Rêgo MJB; Pereira MC; Duarte ALBP; Abdalla DSP; Nicco C; Batteux F; da Rocha Pitta MG
Inflammopharmacology; 2024 Feb; 32(1):433-446. PubMed ID: 37477795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
